Birdwatch Archive

Birdwatch Note Rating

2023-03-18 21:02:06 UTC - HELPFUL

Rated by Participant: 4C77E5537D9CEDEADF4B1D3947378FFA550297940A635BADB09945E3C807DA85
Participant Details

Original Note:

Context needed: The puberty blocker Lupron was trialled and approved by FDA for precocious puberty not gender affirmation. Lupron is being used ‘off label’ and there are no long-term studies currently available on the effects of this blocker on fertility and sexual function. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020263s050lbl.pdf

All Note Details

Original Tweet

All Information

  • noteId - 1636840477109501952
  • participantId -
  • raterParticipantId - 4C77E5537D9CEDEADF4B1D3947378FFA550297940A635BADB09945E3C807DA85
  • createdAtMillis - 1679173326635
  • version - 2
  • agree - 0
  • disagree - 0
  • helpful - 0
  • notHelpful - 0
  • helpfulnessLevel - HELPFUL
  • helpfulOther - 0
  • helpfulInformative - 0
  • helpfulClear - 0
  • helpfulEmpathetic - 0
  • helpfulGoodSources - 1
  • helpfulUniqueContext - 0
  • helpfulAddressesClaim - 1
  • helpfulImportantContext - 1
  • helpfulUnbiasedLanguage - 0
  • notHelpfulOther - 0
  • notHelpfulIncorrect - 0
  • notHelpfulSourcesMissingOrUnreliable - 0
  • notHelpfulOpinionSpeculationOrBias - 0
  • notHelpfulMissingKeyPoints - 0
  • notHelpfulOutdated - 0
  • notHelpfulHardToUnderstand - 0
  • notHelpfulArgumentativeOrBiased - 0
  • notHelpfulOffTopic - 0
  • notHelpfulSpamHarassmentOrAbuse - 0
  • notHelpfulIrrelevantSources - 0
  • notHelpfulOpinionSpeculation - 0
  • notHelpfulNoteNotNeeded - 0
  • ratingsId - 16368404771095019524C77E5537D9CEDEADF4B1D3947378FFA550297940A635BADB09945E3C807DA85